1. Shan, Enfang, Cao, Yi-Nan, Zhang, Yang, Zhi, Tongle, Li, Xianwen. 2023. Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma. In BMC cancer, 23, 846. doi:10.1186/s12885-023-10896-1. https://pubmed.ncbi.nlm.nih.gov/37697240/
2. Spencer, Kylee L, Olson, Lana M, Schnetz-Boutaud, Nathalie, Pericak-Vance, Margaret A, Haines, Jonathan L. 2011. Dissection of chromosome 16p12 linkage peak suggests a possible role for CACNG3 variants in age-related macular degeneration susceptibility. In Investigative ophthalmology & visual science, 52, 1748-54. doi:10.1167/iovs.09-5112. https://pubmed.ncbi.nlm.nih.gov/21169531/
3. Everett, Kate V, Chioza, Barry, Aicardi, Jean, Rees, Michele, Gardiner, Mark. 2007. Linkage and association analysis of CACNG3 in childhood absence epilepsy. In European journal of human genetics : EJHG, 15, 463-72. doi:. https://pubmed.ncbi.nlm.nih.gov/17264864/
4. Avazzadeh, Sahar, Quinlan, Leo R, Reilly, Jamie, Shen, Sanbing, Gallagher, Louise. 2021. NRXN1α+/- is associated with increased excitability in ASD iPSC-derived neurons. In BMC neuroscience, 22, 56. doi:10.1186/s12868-021-00661-0. https://pubmed.ncbi.nlm.nih.gov/34525970/
5. Khojasteh-Leylakoohi, Fatemeh, Mohit, Reza, Khalili-Tanha, Nima, Batra, Jyotsna, Avan, Amir. 2023. Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer. In Scientific reports, 13, 16678. doi:10.1038/s41598-023-42928-y. https://pubmed.ncbi.nlm.nih.gov/37794108/